SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 46 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,443,663 | +1.3% | 3,505,000 | 0.0% | 0.00% | – |
| Q3 2022 | $3,400,000 | -19.6% | 3,505,000 | -19.5% | 0.00% | – |
| Q2 2022 | $4,227,000 | -38.9% | 4,355,000 | -38.3% | 0.00% | – |
| Q1 2022 | $6,919,000 | -23.7% | 7,055,000 | -23.4% | 0.00% | – |
| Q4 2021 | $9,072,000 | +0.3% | 9,205,000 | 0.0% | 0.00% | – |
| Q3 2021 | $9,043,000 | +16.4% | 9,205,000 | +16.4% | 0.00% | – |
| Q2 2021 | $7,772,000 | +4.6% | 7,905,000 | +2.6% | 0.00% | – |
| Q1 2021 | $7,428,000 | +123.5% | 7,705,000 | +119.8% | 0.00% | – |
| Q4 2020 | $3,324,000 | +183.1% | 3,505,000 | +174.9% | 0.00% | – |
| Q3 2020 | $1,174,000 | +4.6% | 1,275,000 | 0.0% | 0.00% | – |
| Q2 2020 | $1,122,000 | +59.6% | 1,275,000 | +45.7% | 0.00% | – |
| Q1 2020 | $703,000 | -18.3% | 875,000 | -7.9% | 0.00% | – |
| Q4 2019 | $860,000 | -2.3% | 950,000 | 0.0% | 0.00% | – |
| Q3 2019 | $880,000 | -5.1% | 950,000 | 0.0% | 0.00% | – |
| Q2 2019 | $927,000 | – | 950,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|